- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00273585
Study of Using Computerized Education to Increase Patients' Confidence in Their Ability to Be Screened for Colon Cancer
September 6, 2006 updated by: University of California, Davis
Randomized Controlled Trial of Software-Based Enhancement of Colorectal Cancer Screening Self-Efficacy
The purpose of this study is to determine whether a newly developed educational software program is effective in increasing patients' confidence in their ability to undergo colon cancer screening.
If the software is effective in this regard, the study will also determine if increased confidence to undergo screening leads to more people being screened and to people feeling as though their decision about screening was informed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Background: Interactive multimedia computer programs (IMCPs) show promise for facilitating informed patient decisions.
However, it is unclear whether IMCPs can activate patients by delivering personally tailored information to bolster self-efficacy, a key mediator of health behavior.
It is also unclear whether IMCPs might be employed to lessen disparities in care experienced by less educated people by tailoring self-efficacy enhancing information to educational level and compensating for provider biases in communication.
Finally, the optimal way to deploy IMPCs in primary care (e.g.
before versus following an office visit) remains unclear.
Aims/Hypotheses: We will compare changes in colorectal cancer (CRC) screening self-efficacy, intention, uptake, and informed decision making resulting from an IMCP providing personally tailored information (to subject educational level and self-efficacy) intended to boost self-efficacy with changes resulting from a non-tailored control IMCP.
We hypothesize both the intervention and control condition will result in increases in CRC screening self-efficacy, but increases will be significantly greater in the intervention group.
We also hypothesize both the intervention and control condition will increase CRC screening intention, uptake, and informed decision making, but increases will be greater in the intervention group and will be mediated by self-efficacy enhancement.
Methods: Pilot randomized controlled trial (RCT) of 2 groups, comparing a PCN office visit-linked, tailored (to subject self-efficacy) IMCP software program plus mailed reminders versus a non-tailored CRC screening IMCP software program plus mailed reminders (control).
Screening methods targeted will be fecal occult blood testing, flexible sigmoidoscopy, colonoscopy, and computed tomographic virtual colonoscopy.
Primary outcomes will be CRC screening self-efficacy, intention, uptake, and informed decision making.
Implications: Our pilot is powered to detect a significant effect on CRC screening self-efficacy but not other outcomes; however, by conducting it as we would a future and larger RCT, we will determine protocol feasibility.
If our hypotheses are confirmed, it would imply cancer screening IMCPs should be focused on enhancing self-efficacy.
Since self-efficacy is a mediator of many patient and health care provider behaviors, it would also imply that similar IMCPs could be developed to support a host of patient and professional education efforts.
Study Type
Interventional
Enrollment
100
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- Department of Family & Community Medicine, UC Davis School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 50
- Able to read and speak English
- Have a telephone and permanent mailing address
- Have adequate vision, hearing, and hand function to utilize a multimedia software program on a laptop computer
- Lack up to date status for CRC screening
Exclusion Criteria:
- Personal history of biopsy-proven colorectal adenoma or CRC
- Personal history of inflammatory bowel disease involving the colon, unless limited to the rectum
- Current symptoms worrisome for colorectal neoplasm (e.g. rectal bleeding, change in stool caliber)
- Colorectal cancer in 1 or more first degree relatives
- Familial adenomatous polyposis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Colorectal cancer screening self-efficacy
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Colorectal cancer screening intention
|
|
Colorectal cancer screening decisional conflict
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anthony F Jerant, MD, Department of Family & Community Medicine, UC Davis School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2005
Study Completion
February 1, 2006
Study Registration Dates
First Submitted
January 6, 2006
First Submitted That Met QC Criteria
January 6, 2006
First Posted (Estimate)
January 9, 2006
Study Record Updates
Last Update Posted (Estimate)
September 8, 2006
Last Update Submitted That Met QC Criteria
September 6, 2006
Last Verified
September 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200412524-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.